Zhirong Zhan
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 18
- Peptidase Inhibition and Analysis 5
- Cancer-related Molecular Pathways 3
- Cell Biology top 5%
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 8
- Cancer therapeutics and mechanisms 6
- Epigenetics and DNA Methylation 3
- DNA and Nucleic Acid Chemistry 3
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Co-authors
- Susan E. BatesTito FojoRobert W. RobeyThomas LitmanParaskevi GiannakakouYoon‐Koo KangMarianne S. PoruchynskyJeroen Buters
- Journals
- Blood (6 papers)Journal of Cellular Biochemistry (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)
- Partner nations
- United StatesItalySouth Korea
In The Last Decade
Zhirong Zhan
33 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.8k
- Cell Biology 378
- Molecular Biology 1.6k
- Pediatrics, Perinatology and Child Health 438
- Cancer Research 317
Countries citing papers authored by Zhirong Zhan
This map shows the geographic impact of Zhirong Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhirong Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhirong Zhan more than expected).
Fields of papers citing papers by Zhirong Zhan
This network shows the impact of papers produced by Zhirong Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhirong Zhan. The network helps show where Zhirong Zhan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhirong Zhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 11 | |
| 2 | [Nasal mucosa remodeling in chronic rhinosinusitis without nasal polyps]. | 2013 | 1 |
| 3 | 2013 | 23 | |
| 4 | 2011 | 43 | |
| 5 | 2011 | 64 | |
| 6 | 2009 | 86 | |
| 7 | 2009 | 64 | |
| 8 | 2008 | 137 | |
| 9 | Pharmacokinetic and biomarker analysis in a phase II trial of the HDAC inhibitor romidepsin, FK228 | 2008 | 1 |
| 10 | ABCG2 expression, function and a SNP variant in the NCI drug screen cell lines | 2006 | 1 |
| 11 | 2004 | 152 | |
| 12 | 2003 | 4 | |
| 13 | 2002 | 103 | |
| 14 | 2000 | 11 | |
| 15 | 2000 | 53 | |
| 16 | Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.breakdown → | 1999 | 674 |
| 17 | 1998 | 9 | |
| 18 | 1997 | 88 | |
| 19 | 1997 | 26 | |
| 20 | Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerizationbreakdown → | 1997 | 594 |
About Zhirong Zhan
Zhirong Zhan is a scholar working on Oncology, Molecular Biology, Cancer Research, Otorhinolaryngology and Pharmaceutical Science, having authored 33 papers that have together received 2.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), Histone Deacetylase Inhibitors Research (8 papers), Cancer therapeutics and mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (1.8k citations), Cell Biology (378 citations), Molecular Biology (1.6k citations), Pediatrics, Perinatology and Child Health (438 citations) and Cancer Research (317 citations). Zhirong Zhan has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include Susan E. Bates, Tito Fojo, Robert W. Robey, Thomas Litman, Paraskevi Giannakakou, Yoon‐Koo Kang, Marianne S. Poruchynsky, Jeroen Buters, Dan L. Sackett and Lyn A. Mickley. Their work appears in journals such as Blood, Journal of Cellular Biochemistry, The Journal of Clinical Endocrinology & Metabolism, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.